Effect of i-PRF and LLLT on Free Gingival Graft Shrinkage
The Effect of Injectable Platelet-Rich Fibrin and Low-Level Laser Therapy on Graft Shrinkage in Free Gingival Grafts: A Randomized Controlled Clinical Trial
1 other identifier
interventional
48
1 country
1
Brief Summary
This randomized clinical trial aims to evaluate whether injectable platelet-rich fibrin (i-PRF) and low-level laser therapy (LLLT) can reduce graft shrinkage after free gingival graft procedures. Free gingival grafts are commonly used to increase the width of keratinized tissue around teeth, but the graft often shrinks during healing. In this study, patients will receive standard free gingival graft surgery with or without additional i-PRF or laser therapy. The goal is to determine whether these treatments improve healing and help maintain the size of the graft.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 11, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedDecember 24, 2025
December 1, 2025
1.2 years
December 11, 2025
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Graft Area Shrinkage (%)
Change in graft surface area, expressed as percentage shrinkage from baseline. Standardized clinical photographs taken at baseline and at postoperative 1, 3, and 6 months were analyzed using calibrated digital image analysis software (ImageJ). The graft borders were traced, and surface area (mm²) was calculated. Each measurement was repeated three times, and the mean value was used. Shrinkage percentage was calculated using the formula: Shrinkage % = \[(baseline area - follow-up area) / baseline area\] × 100.
Baseline, 1 month, 3 months, and 6 months postoperatively.
Root Coverage Percentage (%)
Percentage of root coverage obtained at 6 months. Root coverage was calculated from changes in gingival recession depth (RD) using the formula: Root Coverage % = \[(baseline RD - RD at 6 months) / baseline RD\] × 100. RD was defined as the distance from the CEJ to the gingival margin and measured using a manual periodontal probe.
Baseline and 6 months postoperatively.
Gingival Recession Depth (RD)
Change in gingival recession depth measured in millimeters.
Baseline, 1 month, 3 months, and 6 months postoperatively.
Keratinized Tissue Height (KTH)
Change in keratinized tissue height measured in millimeters.
Baseline, 1 month, 3 months, and 6 months postoperatively.
Secondary Outcomes (6)
Probing Depth (PD)
Baseline, 1 month, 3 months, and 6 months postoperatively.
Clinical Attachment Level (CAL)
Baseline, 1 month, 3 months, and 6 months postoperatively.
Oedema Score in the Recipient Site
Postoperative days 3, 5, 7, 14, 21, and 28.
Erythema Score in the Recipient Site
Postoperative days 3, 5, 7, 14, 21, and 28.
Pain Intensity (VAS Score)
First postoperative week.
- +1 more secondary outcomes
Study Arms (3)
Control Group
ACTIVE COMPARATORPatients receive free gingival graft only without additional treatment.
i-PRF group
EXPERIMENTALPatients receive free gingival graft with injectable platelet-rich fibrin applied to the graft surface.
LLLT Group
EXPERIMENTALPatients receive free gingival graft with low-level laser therapy applied immediately after surgery and on postoperative days 3, 5, 7, and 14.
Interventions
Autologous platelet-rich fibrin gel is applied to the graft surface after free gingival graft surgery to potentially reduce graft shrinkage.
Low-level laser therapy is applied to the graft site immediately after surgery and on postoperative days 3, 5, 7, and 14 to potentially improve healing and reduce graft shrinkage.
Standard free gingival graft procedure performed without additional treatments.
Eligibility Criteria
You may qualify if:
- Age \> 18 years.
- Systemically healthy.
- Cairo Class I gingival recession in vital mandibular anterior incisors.
- No caries or restorations in the relevant teeth.
- Keratinized gingiva height \< 2 mm in the included teeth.
- Plaque Index (PI) \< 1.
- Gingival Index (GI) \< 1.
You may not qualify if:
- Active periodontal disease or probing depth \> 3 mm.
- Use of medications that could prevent surgery or affect wound healing.
- Pregnancy or breastfeeding.
- History of periodontal surgery in the working area.
- Active smokers.
- Current orthodontic treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaraş Sütçü İmam University
Kahramanmaraş, Turkey (Türkiye)
Related Publications (1)
Shakiliyeva S, Sahin D, Gunpinar S, Gursel M. Comparison of conventional and modified sling suture techniques in free gingival graft operations-a randomized controlled clinical trial. BMC Oral Health. 2025 Feb 21;25(1):279. doi: 10.1186/s12903-025-05456-x.
PMID: 39984903BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
esra bozkurt
Kahramanmaras Sutcu Imam University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 11, 2025
First Posted
December 24, 2025
Study Start
July 1, 2024
Primary Completion
August 30, 2025
Study Completion
August 30, 2025
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to ensure patient privacy and confidentiality.